WO2001007607A3 - FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY - Google Patents

FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY Download PDF

Info

Publication number
WO2001007607A3
WO2001007607A3 PCT/JP2000/004895 JP0004895W WO0107607A3 WO 2001007607 A3 WO2001007607 A3 WO 2001007607A3 JP 0004895 W JP0004895 W JP 0004895W WO 0107607 A3 WO0107607 A3 WO 0107607A3
Authority
WO
WIPO (PCT)
Prior art keywords
full length
proteins
cdna clones
length cdna
proteins encoded
Prior art date
Application number
PCT/JP2000/004895
Other languages
French (fr)
Other versions
WO2001007607A8 (en
WO2001007607A2 (en
Inventor
Toshio Ota
Takao Isogai
Tetsuo Nishikawa
Yuri Kawai
Original Assignee
Helix Res Inst
Toshio Ota
Takao Isogai
Tetsuo Nishikawa
Yuri Kawai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Res Inst, Toshio Ota, Takao Isogai, Tetsuo Nishikawa, Yuri Kawai filed Critical Helix Res Inst
Priority to AU60227/00A priority Critical patent/AU6022700A/en
Priority to JP2001512876A priority patent/JP2003516717A/en
Publication of WO2001007607A2 publication Critical patent/WO2001007607A2/en
Publication of WO2001007607A3 publication Critical patent/WO2001007607A3/en
Publication of WO2001007607A8 publication Critical patent/WO2001007607A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Novel human proteins and DNAs encoding the proteins are provided.Four kinds of human proteins and full length cDNAs encoding these proteins have been isolated. The full length cDNAs of the present invention have been isolated from a cDNA library derived from progenitor cells and are used to produce these proteins.
PCT/JP2000/004895 1999-07-23 2000-07-21 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY WO2001007607A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU60227/00A AU6022700A (en) 1999-07-23 2000-07-21 Full length cdna clones and proteins encoded thereby
JP2001512876A JP2003516717A (en) 1999-07-23 2000-07-21 Full-length cDNA clone and protein encoding it

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP20981799 1999-07-23
JP11/209817 1999-07-23
US15952899P 1999-10-18 1999-10-18
US60/159,528 1999-10-18

Publications (3)

Publication Number Publication Date
WO2001007607A2 WO2001007607A2 (en) 2001-02-01
WO2001007607A3 true WO2001007607A3 (en) 2001-05-17
WO2001007607A8 WO2001007607A8 (en) 2001-06-21

Family

ID=26517680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/004895 WO2001007607A2 (en) 1999-07-23 2000-07-21 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY

Country Status (3)

Country Link
JP (1) JP2003516717A (en)
AU (1) AU6022700A (en)
WO (1) WO2001007607A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1293569A3 (en) * 2001-09-14 2004-03-31 Research Association for Biotechnology Full-length cDNAs
JP2003088388A (en) 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk NEW FULL-LENGTH cDNA
JP2003135075A (en) 2001-11-05 2003-05-13 Research Association For Biotechnology NEW FULL-LENGTH cDNA
EP1308459A3 (en) * 2001-11-05 2003-07-09 Research Association for Biotechnology Full-length cDNA sequences

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020750A1 (en) * 1997-10-22 1999-04-29 Helix Research Institute METHOD FOR SCREENING FULL-LENGTH cDNA CLONES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020750A1 (en) * 1997-10-22 1999-04-29 Helix Research Institute METHOD FOR SCREENING FULL-LENGTH cDNA CLONES

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCES 31 October 1997 (1997-10-31), CHEN X. ET AL.: "fmfc2 regional genomic DNA specific cDNA library, H. sapiens cDNA clone CR18-9.", XP002150622 *
SHERIDAN K.M. & MALTESE W.A.: "Expression of Rab3a GTPase and other synaptic proteins is induced in differentiated NT2N neurons.", J. MOL. NEUROSCIENCE, vol. 10, April 1998 (1998-04-01), pages 121 - 128, XP000952944 *

Also Published As

Publication number Publication date
AU6022700A (en) 2001-02-13
WO2001007607A8 (en) 2001-06-21
JP2003516717A (en) 2003-05-20
WO2001007607A2 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
IL196509A0 (en) Antibodies directed aganist polypeptides capable of binding to ldcam, and pharmaceutical compositions comprising the same
EP1308459A3 (en) Full-length cDNA sequences
WO1998021328A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
CA2129820A1 (en) Dna sequences encoding novel growth/differentiation factors
WO1994012645A3 (en) Cdna clone for human inducible nitric oxyde synthase and process for preparing same
WO1999006549B1 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
WO1999054461A3 (en) Human nucleic acid sequences of endometrium tumour tissue
WO1999051727A3 (en) Human nucleic acid sequences of normal ovary tissue
WO2001007607A3 (en) FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY
EP1447413A3 (en) Full-length human cDNA
WO1999054447A3 (en) Human nucleic acid sequences of bladder tumour tissue
AU1694195A (en) cDNA and genomic clones encoding human my opiate receptor and the purified gene product
AU1073599A (en) Production of kappa-casein macropeptide
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
AU689887B2 (en) Oligonucleotides to inhibit the expression of isoprenyl protein transferases
ITMI961098A0 (en) IMPROVED PROCEDURE FOR THE PRODUCTION OF POLYESTER RESINS
AU7965198A (en) Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides
WO1998024896A3 (en) Muteins of obese protein
AU1398595A (en) Peptide analogs of the factor ixa platelet binding site
EP0905234A3 (en) Allelic variant of human STAT3
AU8747098A (en) Human galectin-9-like proteins and cdnas encoding these proteins
WO2002072632A3 (en) Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
ZA978219B (en) The production of solid pharmaceutical forms
EP1097999A3 (en) Abscisic acid responsive element-binding transcription factors
AU9281998A (en) Proteins alike to human complement factor h and cdnas encoding these proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase